This is a non-core endpoint: only basic statistics are computed.

Other transitory neonatal endocrine disorders

Endpoint Browser

P16_OTH_TRANSITO_NEONTAL_ENDOCR_DISORD

No definition available.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P72 Cause of death: ICD-10 — P72 2 out of 7 registries used, show all original rules.	9
4. Check minimum number of events None	9
5. Include endpoints None	9
6. Filter based on genotype QC (FinnGen only)	8

Control definitions (FinnGen only)

Control exclude: P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P7[0-4]
Name in latin: Aliae perturbationes transitoriae neonatales endocrinae

NAME	P16_OTH_TRANSITO_NEONTAL_ENDOCR_DISORD
CONTROL_EXCLUDE	P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P72
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P72
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other transitory neonatal endocrine disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	183	94	89
Only index persons	94	45	49
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	0.01	0.01
Only index persons	0.02	0.03	0.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8	6	-
Unadjusted period prevalence (%)	0.00	0.00	-
Median age at first event (years)	0.17	0.18	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029937) Albumin [Presence] in Urine by Test strip

0.00

0.70

0.0

6.4

—

0.00

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.00

0.69

0.0

4.7

—

0.00

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.46

0.0

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.46

0.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.46

0.0

3.1

—

(3008898) HLA-B27 [Presence]

0.00

0.23

0.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.23

0.0

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.00

0.23

0.0

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.23

0.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

0.00

0.23

0.0

4.7

—

243.90

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.0

2.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.8

—

(40761535) Cells panel - Urine sediment

0.00

0.0

3.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.00

0.0

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

0.00

0.0

6.6

—

1.02

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.27

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

0.22

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.0

2.6

—

24.12

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

2.8

—

24.40

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

113.00

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.00

0.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

0.00

0.0

11.8

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.0

4.2

—

43.60

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3045414) Leukocytes [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3000492) Spirometry study

0.00

-0.00

0.0

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

24.97

—

(40768797) Stomach Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

8.3

—

39.13

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_OTH_TRANSITO_NEONTAL_ENDOCR_DISORD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_OTH_TRANSITO_NEONTAL_ENDOCR_DISORD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_OTH_TRANSITO_NEONTAL_ENDOCR_DISORD – Other transitory neonatal endocrine disorders

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other transitory neonatal endocrine disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints